Segall Bryant & Hamill, LLC Embecta Corp. Transaction History
Segall Bryant & Hamill, LLC
- $7.1 Billion
- Q3 2025
A detailed history of Segall Bryant & Hamill, LLC transactions in Embecta Corp. stock. As of the latest transaction made, Segall Bryant & Hamill, LLC holds 137,186 shares of EMBC stock, worth $2 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
137,186
Previous 138,223
0.75%
Holding current value
$2 Million
Previous $1.34 Million
44.51%
% of portfolio
0.03%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding EMBC
# of Institutions
410Shares Held
56.8MCall Options Held
345KPut Options Held
68.7K-
Black Rock Inc. New York, NY9.19MShares$134 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.46MShares$79.5 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO5.19MShares$75.5 Million0.04% of portfolio
-
River Road Asset Management, LLC3.25MShares$47.2 Million0.58% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY2.62MShares$38.1 Million0.69% of portfolio
About Embecta Corp.
- Ticker EMBC
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 57,836,500
- Market Cap $842M
- Description
- Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...